Operating Lease, Liability of Y-mAbs Therapeutics, Inc. from 31 Mar 2019 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Y-mAbs Therapeutics, Inc. quarterly Operating Lease, Liability in USD history and change rate from 31 Mar 2019 to 30 Jun 2025.
  • Y-mAbs Therapeutics, Inc. Operating Lease, Liability for the quarter ending 30 Jun 2025 was $3,124,000, a 145% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)

Y-mAbs Therapeutics, Inc. Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $3,124,000 +$1,850,000 +145% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $603,000 -$578,000 -49% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $820,000 -$599,000 -42% 31 Dec 2024 10-Q 08 Aug 2025 2025 Q2
Q3 2024 $1,075,000 -$548,000 -34% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $1,274,000 +$29,000 +2.3% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $1,181,000 -$303,000 -20% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $1,419,000 -$348,000 -20% 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 $1,623,000 -$596,000 -27% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $1,245,000 -$1,149,000 -48% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $1,484,000 -$1,565,000 -51% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $1,767,000 -$1,867,000 -51% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $2,219,000 -$284,000 -11% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $2,394,000 -$608,000 -20% 30 Jun 2022 10-Q 08 Aug 2022 2021 Q3
Q1 2022 $3,049,000 -$437,000 -13% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $3,634,000 -$345,000 -8.7% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $2,503,000 -$1,901,000 -43% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $3,002,000 +$1,034,000 +53% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $3,486,000 +$1,395,000 +67% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $3,979,000 +$1,749,000 +78% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $4,404,000 +$2,067,000 +88% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $1,968,000 -$514,000 -21% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $2,091,000 -$559,000 -21% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $2,230,000 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $2,337,000 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 $2,482,000 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $2,650,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.